NO20082748L - Aryl-isoksazol-4-yl-imidazo[1, 5-a]pyridinderivater - Google Patents
Aryl-isoksazol-4-yl-imidazo[1, 5-a]pyridinderivaterInfo
- Publication number
- NO20082748L NO20082748L NO20082748A NO20082748A NO20082748L NO 20082748 L NO20082748 L NO 20082748L NO 20082748 A NO20082748 A NO 20082748A NO 20082748 A NO20082748 A NO 20082748A NO 20082748 L NO20082748 L NO 20082748L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- hydrogen
- aryl
- isoxazol
- imidazo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05112988 | 2005-12-27 | ||
PCT/EP2006/069792 WO2007074089A1 (en) | 2005-12-27 | 2006-12-18 | Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082748L true NO20082748L (no) | 2008-09-24 |
Family
ID=37909303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082748A NO20082748L (no) | 2005-12-27 | 2008-06-13 | Aryl-isoksazol-4-yl-imidazo[1, 5-a]pyridinderivater |
Country Status (17)
Country | Link |
---|---|
US (1) | US7399769B2 (pt) |
EP (1) | EP1968977B1 (pt) |
JP (1) | JP4864982B2 (pt) |
KR (1) | KR101033719B1 (pt) |
CN (1) | CN101346377B (pt) |
AR (1) | AR058728A1 (pt) |
AT (1) | ATE537171T1 (pt) |
AU (1) | AU2006331363B2 (pt) |
BR (1) | BRPI0620760A2 (pt) |
CA (1) | CA2633536A1 (pt) |
ES (1) | ES2376357T3 (pt) |
IL (1) | IL192236A0 (pt) |
NO (1) | NO20082748L (pt) |
RU (1) | RU2420527C2 (pt) |
TW (1) | TWI324156B (pt) |
WO (1) | WO2007074089A1 (pt) |
ZA (1) | ZA200805354B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1968973T3 (pl) | 2005-12-27 | 2012-03-30 | Hoffmann La Roche | Pochodne aryloizoksazol-4-iloimidazolu |
BRPI0814718A2 (pt) | 2007-06-22 | 2015-02-24 | Hoffmann La Roche | Derivados de isoxazol-imidazol |
AU2008333326B2 (en) | 2007-12-04 | 2013-05-30 | F. Hoffmann-La Roche Ag | Isoxazolo-pyridine derivatives |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
WO2014001280A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
JP6223443B2 (ja) | 2012-06-26 | 2017-11-01 | サニオナ・エイピイエス | フェニルトリアゾール誘導体及びgabaa受容体複合体を調節するための該フェニルトリアゾール誘導体の使用 |
WO2014001278A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
WO2014001279A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
KR20150033678A (ko) | 2012-06-26 | 2015-04-01 | 사니오나 에이피에스 | 페닐 트리아졸 유도체 및 이의 gabaa 수용체 복합체 조절용 용도 |
LT3105218T (lt) | 2014-02-13 | 2019-12-10 | Incyte Corp | Ciklopropilaminai kaip lsd1 inhibitoriai |
US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
TWI720451B (zh) | 2014-02-13 | 2021-03-01 | 美商英塞特控股公司 | 作為lsd1抑制劑之環丙胺 |
TWI687419B (zh) | 2014-07-10 | 2020-03-11 | 美商英塞特公司 | 作為lsd1抑制劑之咪唑并吡啶及咪唑并吡嗪 |
WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
US9695180B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors |
TWI714567B (zh) | 2015-04-03 | 2021-01-01 | 美商英塞特公司 | 作為lsd1抑制劑之雜環化合物 |
CR20180152A (es) | 2015-08-12 | 2018-08-09 | Incyte Corp | Sales de un inhibidor de lsd1 |
BR102019014802A2 (pt) | 2018-07-20 | 2020-02-04 | Boehringer Ingelheim Int | difluorometil-fenil triazóis |
US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1481701A (en) * | 1999-11-12 | 2001-06-06 | Neurogen Corporation | Bicyclic and tricyclic heteroaromatic compounds |
ES2299618T3 (es) * | 2001-11-20 | 2008-06-01 | Eli Lilly And Company | Agonistas beta-3-adrenergicos. |
-
2006
- 2006-12-18 AU AU2006331363A patent/AU2006331363B2/en not_active Ceased
- 2006-12-18 RU RU2008125040/04A patent/RU2420527C2/ru not_active IP Right Cessation
- 2006-12-18 WO PCT/EP2006/069792 patent/WO2007074089A1/en active Application Filing
- 2006-12-18 ES ES06841391T patent/ES2376357T3/es active Active
- 2006-12-18 AT AT06841391T patent/ATE537171T1/de active
- 2006-12-18 US US11/640,768 patent/US7399769B2/en not_active Expired - Fee Related
- 2006-12-18 KR KR1020087015509A patent/KR101033719B1/ko not_active IP Right Cessation
- 2006-12-18 BR BRPI0620760-0A patent/BRPI0620760A2/pt not_active IP Right Cessation
- 2006-12-18 CN CN2006800491806A patent/CN101346377B/zh not_active Expired - Fee Related
- 2006-12-18 CA CA002633536A patent/CA2633536A1/en not_active Abandoned
- 2006-12-18 EP EP06841391A patent/EP1968977B1/en not_active Not-in-force
- 2006-12-18 JP JP2008547940A patent/JP4864982B2/ja not_active Expired - Fee Related
- 2006-12-25 TW TW095148805A patent/TWI324156B/zh not_active IP Right Cessation
- 2006-12-26 AR ARP060105770A patent/AR058728A1/es not_active Application Discontinuation
-
2008
- 2008-06-13 NO NO20082748A patent/NO20082748L/no not_active Application Discontinuation
- 2008-06-16 IL IL192236A patent/IL192236A0/en unknown
- 2008-06-19 ZA ZA200805354A patent/ZA200805354B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US7399769B2 (en) | 2008-07-15 |
KR101033719B1 (ko) | 2011-05-09 |
ZA200805354B (en) | 2009-10-28 |
JP4864982B2 (ja) | 2012-02-01 |
RU2420527C2 (ru) | 2011-06-10 |
IL192236A0 (en) | 2008-12-29 |
BRPI0620760A2 (pt) | 2011-11-22 |
RU2008125040A (ru) | 2010-02-10 |
AU2006331363A1 (en) | 2007-07-05 |
CN101346377A (zh) | 2009-01-14 |
EP1968977B1 (en) | 2011-12-14 |
EP1968977A1 (en) | 2008-09-17 |
CA2633536A1 (en) | 2007-07-05 |
CN101346377B (zh) | 2011-05-11 |
AR058728A1 (es) | 2008-02-20 |
ATE537171T1 (de) | 2011-12-15 |
ES2376357T3 (es) | 2012-03-13 |
KR20080072072A (ko) | 2008-08-05 |
US20070191421A1 (en) | 2007-08-16 |
WO2007074089A1 (en) | 2007-07-05 |
TWI324156B (en) | 2010-05-01 |
JP2009521517A (ja) | 2009-06-04 |
AU2006331363B2 (en) | 2012-07-05 |
TW200734328A (en) | 2007-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082748L (no) | Aryl-isoksazol-4-yl-imidazo[1, 5-a]pyridinderivater | |
NO20082956L (no) | Aryl-isoksazol-4-yl-imidazo[1,2-A]pyridin anvendbar for behandling av Alzheimers sykdom via GABA-reseptorer | |
CN111741769B (zh) | 一种多功能化合物、其制备方法及其在医药上的应用 | |
EP3209656B1 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
JP5933746B2 (ja) | イミダゾリジンジオン系化合物およびその用途 | |
NO20082719L (no) | Aryl-isoksazol-4-yl-oksadiazolderivater | |
BR112017018832B1 (pt) | Profármacos de riluzol e seu uso e composição | |
JP2022503942A (ja) | イソインドリン化合物、その調製方法、医薬組成物および使用 | |
WO2009134617A1 (en) | Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
NO20082747L (no) | Arylisoksazol-4-yl-imidazolderivater | |
CN103402987A (zh) | 6-氨基-2-苯基氨基-1h-苯并咪唑-5-甲酰胺衍生物及其作为微粒体前列腺素e2合酶-1抑制剂的用途 | |
CN103097382A (zh) | 2-(芳基氨基)-3H-咪唑并[4,5-b]吡啶-6-甲酰胺衍生物及其作为MPGES-1抑制剂的用途 | |
NO20075365L (no) | 3,4-substituerte pyrrolidinderivater for behandling av hypertensjon | |
US10899759B2 (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor M1 | |
WO2016014522A1 (en) | Inhibitors of deubiquitinating proteases | |
JP7130873B2 (ja) | バニン阻害剤としてのヘテロ芳香族化合物 | |
EP2266969A3 (en) | 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors | |
WO2007054444A3 (en) | 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives | |
HUT71353A (en) | 4-[4'-piperidinyl or 3'pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof | |
UA123071C2 (uk) | ІНГІБІТОРИ ДОФАМІН-<font face="Symbol">b</font>-ГІДРОКСИЛАЗИ | |
JP2017531680A (ja) | 三環式アトロプ異性体の化合物 | |
US7476754B2 (en) | Biphenyl derived thiamides as calpain inhibitors | |
CN114127050A (zh) | 适用于稳定化致淀粉样变免疫球蛋白轻链的苯并吡喃和咪唑衍生物 | |
Hashem et al. | Synthesis and reactions of some 2 (3H)-and 2 (5H)-furanone derivatives: a comparative study | |
BR0205683A (pt) | Processo para a preparação de derivados de piperazina, e, mesilato de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |